PD49-11 COMBINING NEDDYLATION INHIBITION WITH CHEMOTHERAPY TO TREAT RENAL MEDULLARY CARCINOMA
2021
INTRODUCTION AND OBJECTIVE:Renal medullary carcinoma (RMC) is a rare and aggressive malignancy that primarily affects young patients of African descent with sickle cell trait. No targeted therapies...
Keywords:
-
Correction
-
Source
-
Cite
-
Save
-
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI